iCoreConnect Inc. Common stock (ICCT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iCoreConnect Inc. Common stock (ICCT) has a cash flow conversion efficiency ratio of 0.083x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-250.46K) by net assets ($-3.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
iCoreConnect Inc. Common stock - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how iCoreConnect Inc. Common stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ICCT current and long-term liabilities for a breakdown of total debt and financial obligations.
iCoreConnect Inc. Common stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iCoreConnect Inc. Common stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Comanche International Public Company Limited
BK:COMAN
|
-0.055x |
|
Victorian Plumbing Group PLC
LSE:VIC
|
0.226x |
|
Qlife Holding AB
ST:QLIFE
|
0.196x |
|
Real Estate Credit Investments Limited
LSE:RECI
|
-0.049x |
|
COLLPLANT BIOTECH. IS-01
F:CPT
|
N/A |
|
MS INTERNATIONAL plc
LSE:MSI
|
-0.025x |
|
Green Minerals AS
OL:GEM
|
-0.324x |
|
Rebosis Property Fund Ltd
JSE:REA
|
-0.010x |
Annual Cash Flow Conversion Efficiency for iCoreConnect Inc. Common stock (2006–2023)
The table below shows the annual cash flow conversion efficiency of iCoreConnect Inc. Common stock from 2006 to 2023. For the full company profile with market capitalisation and key ratios, see iCoreConnect Inc. Common stock (ICCT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $4.44 Million | $-8.82 Million | -1.986x | -490.21% |
| 2022-12-31 | $-2.50 Million | $-1.27 Million | 0.509x | +117.66% |
| 2021-12-31 | $1.01 Million | $-2.90 Million | -2.881x | -242.62% |
| 2020-12-31 | $-628.94K | $-1.27 Million | 2.020x | +156.35% |
| 2019-12-31 | $465.00K | $-1.67 Million | -3.585x | -274.42% |
| 2018-12-31 | $-958.00K | $-1.97 Million | 2.055x | +36.79% |
| 2017-12-31 | $-1.18 Million | $-1.77 Million | 1.503x | +94.20% |
| 2016-12-31 | $-2.26 Million | $-1.75 Million | 0.774x | +521.11% |
| 2015-12-31 | $-12.96 Million | $-1.61 Million | 0.125x | -3.24% |
| 2013-12-31 | $-12.79 Million | $-1.65 Million | 0.129x | +86.80% |
| 2012-12-31 | $-7.92 Million | $-545.84K | 0.069x | -86.09% |
| 2011-12-31 | $-2.57 Million | $-1.27 Million | 0.495x | +2.49% |
| 2010-12-31 | $-3.56 Million | $-1.72 Million | 0.483x | +117.94% |
| 2009-12-31 | $941.34K | $-2.54 Million | -2.694x | -387.89% |
| 2008-12-31 | $4.11 Million | $-2.27 Million | -0.552x | -21.84% |
| 2006-12-31 | $7.46 Million | $-3.38 Million | -0.453x | -- |
About iCoreConnect Inc. Common stock
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history… Read more